The global botulinum toxin injection market is anticipated to grow at a significant CAGR of 5.9% during the forecast period. Advancements in augmented reality in aesthetic procedures are anticipated to drive the market in the coming years. Augmented reality is computer-generated images on a screen with a real object or a scene. The researchers use high definition 3D camera to capture the image of the facial surface and computed tomography to obtain digital information on the underlying facial bones. Moreover , augmented reality c is expected to act as a guide to planning, performing, and evaluating the results of facial reconstruction. Furthermore, migraine is anticipated as the most prevalent symptom globally. 

The global NT growth factor receptor market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, new product launches, FDA approval, research, and development of new drugs to stay competitive in the market. For instance, in May 2021, FDA grants approval to amivantamab-vmjw, which is a bi-specific antibody directed against epidermal growth factor and MET receptors, for adult patients with locally advanced or metastatic non-small cell lung cancer with epidermal growth factor receptors.

The global vasculitis drug market is projected to grow at a significant CAGR during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers and acquisitions, geographical expansion, new product launch, and product innovation to remain competitive in the marketplace. For instance, in January 2022the European Commission approved Tavneos in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis (GPA) or microscopic polyangiitis (MPA), the two main forms of ANCA-associated vasculitis, according to Vifor Fresenius Medical Care Renal Pharma (VFMCRP). 

The global super disintegrant market is anticipated to grow at a considerable SGR during the forecast year. Super disintegrates are the chemical agent used in medicines for the treatment of various diseases. It works by dissolving quickly in water or saliva when taken directly into the mouth. The major factor driving the growth of the market is the development of generic medicines and the growing adoption of orally disintegrating tablets (ODTs) among patients. Orally disintegrating tablets (ODTs) are tablets made using super disintegrants that dissolve in water very quickly and efficiently provide treatment to the affected area. 

The global Pyrogen Testing market is anticipated to grow at a considerable CAGR of around 8.5%during the forecast period (2022-2028). The rising prevalence of infectious diseases such as HIV/AIDS, Infectious mononucleosis., Influenza (flu), Chickenpox, Common cold among others across the globe, respect to this the demand for pyrogen testing techniques that are utilized for endotoxin and microbial identification are propelling thereby boosting the pyrogen testing market growth. As per the U.S. Department of Health & Human Services, here were approximately 37.7 million people across the globe with HIV in 2020. Of these, 36 million were adults and 1.7 million were children aged 0-14 years.

The global Plant-Based Protein Supplement market is anticipated to grow at a considerable CAGR of around 8.1 % during the forecast period (2022-2028). Rising awareness about animal welfare and also environmental sustainability pushes customers to shift towards it and adopt a plant-based diet. Customers currently are more health-conscious and perception is also evolving that plant base products are safe and more healthy than animal-oriented products. Furthermore, the increasing vegan population and increasing preference for vegetarian diets is propelling manufacturers to develop innovative sources of plant-based proteins. 

The global nano pharmaceutical market is projected to grow at a significant CAGR during the forecast period (2022-2028). Nano pharmaceutical is a medical application for nanotechnology ranging from the medical use of nanomaterials and biological devices to nano-electronic biosensors. A major factor contributing to market growth is the development of new drug delivery technologies and the increasing adoption of nanomedicine and nanotechnologies across various applications worldwide. 

The global face mask market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The major factor driving the growth of the global face mask market during the forecast period is the increasing prevalence of the respiratory disease across the globe. This disease spread due to the deadly pathogen as well as factors such as rising pollution, inappropriate hygiene, smoking habits, and lower immunization among the population. Hence, the growing prevalence of respiratory diseases has increased the usage and sales of face masks which in turn is driving the growth of the market. 

The global automatic and smart pet feeder is anticipated to grow at a considerable CAGR of 21.0% during the forecast period (2022-2028). Ongoing technological advancements such as introduction of a video camera and voice to provide better monitoring of pet is a major factor contributing to demand for automatic and smart pet feeder’s market. Technological innovations such as smart pet feeder with an inbuilt camera and voice controls are gaining popularity among pet owners as they provide more functionality then just automatic and timely feeding. 

The global atipamezole market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The atipamezole market gorwth is driven by the mareting strategies adopted by players for their product approval and launch of new therapies. Increasing demand for the usage of these drugs across the country and it is particularly for an animal in dogs is boosting the market. The initial acquisition of new therapeutics of atipamezole and equipped healthcare infrastructure is also surging the market.